Precision diagnostic service utilizing liquid biopsy technology for early detection and monitoring of malignant tumors. Analyzes circulating biomarkers from patient blood samples. Enables non-invasive assessment of tumor characteristics and treatment response.
Manufactured by
NOROVA
China
NOROVA specializes in personalized precision medicine for malignant tumors, serving as a biomedical innovation and life sciences R&D center in the Beijing-Tianjin region. The company operates a proprietary tumor organoid precision diagnosis platform integrating drug sensitivity testing, high-throughput drug screening, and genetic testing. NOROVA also develops tumor microenvironment organ-on-chip and multi-organ chip technologies for drug development applications.
© 2026 Suplivia · Home · Browse Products